CLPT earnings: real EPS beat/miss history, analyst consensus Buy, P/E -14.88. Updated 2026-07-23.
ClearPoint Neuro (CLPT) Research Hub
ClearPoint Neuro (CLPT) trades on NASDAQ, US in the Healthcare (Medical - Devices) sector. As of 2026-09-11, shares last closed at 13.72 USD (-1.15%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -14.88, market cap 0.45B. This hub links to the full technical, earnings and options research available for CLPT.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Devices) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 13.72 USD (-1.15%) |
| 52-week range | 12.27 USD – 19.41 USD |
| Trend regime | Range |
| 14-day RSI | 46.6 (Neutral) |
| Trailing P/E | -14.88 |
| Market cap | 0.45B |
| Dividend yield | 0.00% |
Available research for CLPT
Covered Call on CLPT: how it works, illustrative setup around the real 13.72 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on CLPT: how it works, illustrative setup around the real 13.72 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on CLPT: how it works, illustrative setup around the real 13.72 USD price, max profit/loss, breakeven and when to use it. Educational.
CLPT technical analysis: range, last 13.72 USD, RSI 46.6, 52w range 12.27 USD–19.41 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is CLPT in?
ClearPoint Neuro (CLPT) is classified under Healthcare (Medical - Devices), listed on NASDAQ, US.
Is CLPT in an uptrend or downtrend?
As of 2026-09-11, CLPT is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is CLPT's trailing P/E ratio?
CLPT's trailing P/E is -14.88, with a market cap of 0.45B. See the earnings research page for full valuation detail.